Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2014 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Expands Biodefense Franchise; Acquires Portfolio of Broad Spectrum Antibiotics

Lead antibiotic candidate currently under DTRA development contract, valued at up to $15 million, as an oral and IV treatment for Burkholderia pseudomallei as well as other bioterror...
November 24, 2014 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Webcast Presentation at 25th Annual Oppenheimer Healthcare Conference

ROCKVILLE, Md., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company will be webcasting its presentation at the 25TH Annual Oppenheimer Healthcare...
November 10, 2014 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Seeks Expanded BioThrax Label; Submits FDA Application for Post-Exposure Prophylaxis

ROCKVILLE, Md., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and...
November 06, 2014 16:01 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Reports Third Quarter and Nine Month 2014 Financial Results

ROCKVILLE, Md., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and nine months ended September 30, 2014. Financial highlights...
October 20, 2014 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Webcast Presentation at Credit Suisse 2014 Healthcare Conference

ROCKVILLE, Md., Oct. 20, 2014 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company will be webcasting its presentation at the Credit Suisse 2014 Healthcare...